Barts Cancer Institute

Campus shot with BCI QM logo

The Barts Cancer Institute (BCI) was created in 2003, and brought together some of the most eminent cancer research teams in London. As part of the Barts and The London School of Medicine and Dentistry, Queen Mary University of London, the BCI has one overriding objective, which is to ensure that the research conducted here is relevant to and will impact on cancer patients.

The BCI is split into six Research Centres, which focus on how to reduce the burden of disease through increasing the chances of survival through early detection and diagnosis; and improve patient survival through the discovery and development of more effective and innovative therapies.

With the Centre for Cancer Prevention at Queen Mary's Wolfson Institute of Preventive Medicine, the BCI is accredited as a Cancer Research UK (CRUK) Centre of Excellence - the CRUK Barts Centre.

Under the leadership of the Director, Professor Nick Lemoine, and supported by an Executive Board of senior investigators, the BCI provides an academic environment fitting for an internationally recognised, comprehensive cancer centre.